These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6340494)

  • 41. Hypertension in obese patients: hemodynamic and volume studies.
    Mujais SK; Tarazi RC; Dustan HP; Fouad FM; Bravo EL
    Hypertension; 1982; 4(1):84-92. PubMed ID: 7061131
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical and hemodynamic effects of medium-term treatment with ketanserin of 2 comparative groups of obese and non-obese hypertensive patients].
    Parrinello G
    Ann Ital Med Int; 1990; 5(4 Pt 2):477-83. PubMed ID: 2102135
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Correlations between blood pressure, blood volume, plasma renin and urinary catecholamines in normal subjects and in patients with benign essential hypertension].
    Weidmann P; Hirsch D; Beretta-Piccoli C; Reubi FC; Ziegler WH
    Schweiz Med Wochenschr; 1976 Dec; 106(49):1741-3. PubMed ID: 1013697
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Decreased venous distensibility in essential hypertension: lack of systemic hemodynamic correlates.
    Simon G; Franciosa JA; Cohn JN
    Angiology; 1979 Mar; 30(3):147-59. PubMed ID: 373515
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Central obesity and hypertension. Relationship between fasting serum insulin, plasma renin activity, and diastolic blood pressure in young obese subjects.
    Licata G; Scaglione R; Ganguzza A; Corrao S; Donatelli M; Parrinello G; Dichiara MA; Merlino G; Cecala MG
    Am J Hypertens; 1994 Apr; 7(4 Pt 1):314-20. PubMed ID: 8031546
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathophysiologic mechanisms in essential hypertension: a clue to the therapeutic approach.
    Messerli FH
    J Cardiovasc Pharmacol; 1984; 6 Suppl 6():S875-9. PubMed ID: 6084143
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Contrasting clinical properties and exercise responses in obese and lean hypertensive patients.
    Weber MA; Neutel JM; Smith DH
    J Am Coll Cardiol; 2001 Jan; 37(1):169-74. PubMed ID: 11153733
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interrelations among blood pressure, blood volume, plasma renin activity and urinary catecholamines in benign essential hypertension.
    Weidmann P; Hirsch D; Beretta-Piccoli C; Reubi FC; Ziegler WH
    Am J Med; 1977 Feb; 62(2):209-18. PubMed ID: 835600
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypertension in obesity.
    Redon J
    Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):344-53. PubMed ID: 11887431
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Left ventricular filling and stress response pattern in essential hypertension.
    Grossman E; Oren S; Messerli FH
    Am J Med; 1991 Nov; 91(5):502-6. PubMed ID: 1951412
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stress response pattern in obesity and systemic hypertension.
    Rockstroh JK; Schmieder RE; Schächinger H; Messerli FH
    Am J Cardiol; 1992 Oct; 70(11):1035-9. PubMed ID: 1414900
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The heart in obesity-hypertension.
    Morse SA; Bravo PE; Morse MC; Reisin E
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):647-58. PubMed ID: 16076275
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Left ventricular filling in the systemic hypertension of obesity.
    Grossman E; Oren S; Messerli FH
    Am J Cardiol; 1991 Jul; 68(1):57-60. PubMed ID: 2058561
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Hemodynamic and biological effects of bromocriptine in essential hypertension].
    Allain H; Daubert JC; Massart C; van den Driessche J; Gouffault J
    Arch Mal Coeur Vaiss; 1982 Sep; 75(9):951-62. PubMed ID: 6816179
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Hemodynamic adaptation in severe obesity with or without arterial hypertension].
    Fazio S; Ferraro S; De Simone G; Santomauro M; Mossetti G; Maddalena G; Turco S; Gravina E; Saccà L
    Cardiologia; 1989 Nov; 34(11):967-72. PubMed ID: 2631990
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute effects of ibopamine hydrochloride on hemodynamics, plasma catecholamine levels, renin activity, aldosterone, metabolism and blood gas in patients with severe congestive heart failure.
    Nakano T; Morimoto Y; Kakuta Y; Konishi T; Kodera T; Kanamaru M; Takezawa H
    Arzneimittelforschung; 1986 Dec; 36(12):1829-34. PubMed ID: 3551968
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Additive effects of obesity and hypertension to limit venous volume.
    Stepniakowski K; Egan BM
    Am J Physiol; 1995 Feb; 268(2 Pt 2):R562-8. PubMed ID: 7864253
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sodium and obesity in the pathogenesis of hypertension.
    Reisin E
    Am J Hypertens; 1990 Feb; 3(2):164-7. PubMed ID: 2155002
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relationship of plasma renin activity and aldosterone levels with hemodynamic functions in essential hypertension.
    London GM; Safar ME; Weiss YA; Corvol PL; Menard JE; Simon AC; Milliez PL
    Arch Intern Med; 1977 Aug; 137(8):1042-7. PubMed ID: 327963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.